ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,595Top JournalGold OA

Bioengineering & Translational Medicine

Abbreviation (ISO):BIOENG. TRANSL. MED
•
Identifier (ISSN):2380-6761(Print)
•
Publisher:Wiley-Blackwell
Clarivate IF (2026)
6.2↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Bioengineering & Translational Medicine

WoS Q1
3710146.09202010.7202110.720227.420236.120245.720256.22026
Annual Impact Factor Metric
Current (2026):6.2
Scopus SJR & RankScopus Q1
1.446
#2,595

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
48

48 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
69articles/year
100% Gold OA•84.41% Original Research

Aims & Scope

Bioengineering & Translational Medicine (abbr: BIOENG. TRANSL. MED, ISSN: 2380-6761) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Wiley-Blackwell in United States. The periodical holds a Journal Impact Factor (JIF) of 6.20, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.446 (Q1), an H-index of 48.

Topics Covered (Recognized by AI)
Biology80%Medicine76.7%Genetics68.6%Chemistry67.5%Biochemistry55.6%Internal medicine52.7%Engineering40.1%Materials science39.5%Physics35.2%Organic chemistry34.3%Pathology34.3%Cell biology30.9%Computer science30%Immunology29.8%Nanotechnology29.8%Psychology24.9%Surgery21.5%Gene20.9%Pharmacology20.4%Quantum mechanics20.4%Chemical engineering20.4%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENGINEERING, BIOMEDICAL

Q1
Rank28/130
IndexSCIE
JCISCIE2026

ENGINEERING, BIOMEDICAL

Q1
Rank24/130
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

11 year
2026Latest
IF6.2
Articles / Year75
Total Citations31
2025
IF5.7
Articles / Year134
Total Citations433
2024
IF6.1
Articles / Year108
Total Citations1,143
2023
IF7.4
Articles / Year166
Total Citations2,860
2022
IF10.684
Articles / Year185
Total Citations5,473

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,595Scopus Q1SCImago Profile
Scopus Coverage:2018, 2020-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyEngineeringPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.446

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
7.24

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,591 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,411
3-Year Documents440
Citable Documents437

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate41.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biomedical EngineeringQ1
BiotechnologyQ1
Pharmaceutical ScienceQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区ENGINEERING, BIOMEDICAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Bioengineering & Translational Medicine (abbr: BIOENG. TRANSL. MED, ISSN: 2380-6761) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Wiley-Blackwell in United States. The periodical holds a Journal Impact Factor (JIF) of 6.20, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.446 (Q1), an H-index of 48.

The journal enforces rigorous peer evaluation with an annual output of approximately 69 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,591 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Wiley-Blackwell
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: a4bcbcdb-3a68-4aa2-88b3-964908fb1f3b
Database Updated: 2026-10-01